Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age
- PMID: 21763385
- DOI: 10.1016/j.vaccine.2011.06.112
Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age
Abstract
Background: Associations between vaccinations, particularly hepatitis B, and onset of rheumatoid arthritis (RA) have been reported, but examined in few large-scale studies.
Method: Onset of RA cases and dates of vaccination against hepatitis B, tetanus, and influenza were identified in a retrospective chart review of approximately 1 million Kaiser Permanente Northern California members ages 15-59 years from 1997 through 1999. In a cohort analysis, rates of new-onset RA were compared between vaccinated and unvaccinated within 90, 180, and 365 days. In a case-control analysis, rates of vaccination during exposure intervals (90, 180, 365, and 730 days) were compared between cases and controls using conditional logistic regression.
Results: 378 RA cases were included in the cohort analysis; 37 additional cases were included in the case-control analysis. In the cohort analysis the relative risks of RA onset within 90, 180, or 365 days of hepatitis B vaccination were not significant (R.R.=1.44, p=0.53; R.R.=1.67, p=0.22; R.R.=1.23, p=0.59 respectively). We found a possible association between RA and influenza vaccine in the previous 180 and 365 days in the cohort analysis (R.R=1.36, p=0.03; R.R.=1.34, p=0.01 respectively), but in the case-control analysis, cases were no more likely than controls to have received any of the three vaccines.
Conclusions: In this large retrospective study we found no statistically significant association between exposure to hepatitis B vaccine and onset of RA. A possible association between RA and influenza vaccination in the cohort study was not borne out in the larger case-control analysis.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Influenza, hepatitis B, and tetanus vaccination coverage among health care personnel in the United States.Am J Infect Control. 2011 Aug;39(6):488-94. doi: 10.1016/j.ajic.2010.10.009. Epub 2011 Feb 2. Am J Infect Control. 2011. PMID: 21288599
-
A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977. Pediatrics. 2008. PMID: 19047220
-
Vaccinations and risk of central nervous system demyelinating diseases in adults.Arch Neurol. 2003 Apr;60(4):504-9. doi: 10.1001/archneur.60.4.504. Arch Neurol. 2003. PMID: 12707063
-
Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?J Autoimmun. 2000 Feb;14(1):1-10. doi: 10.1006/jaut.1999.0346. J Autoimmun. 2000. PMID: 10648110 Review.
-
[Problems of vaccinations during pregnancy].Clin Ter. 1988 Apr 15;125(1):65-70. Clin Ter. 1988. PMID: 2974360 Review. Italian. No abstract available.
Cited by
-
COVID-19 vaccination experience in patients with rheumatoid arthritis treated at a single VA medical center.Vaccine X. 2023 Aug;14:100295. doi: 10.1016/j.jvacx.2023.100295. Epub 2023 Apr 4. Vaccine X. 2023. PMID: 37051228 Free PMC article.
-
C-Reactive protein rise in rheumatology patients following COVID-19 vaccination.Rheumatol Adv Pract. 2023 Mar 24;7(Suppl 1):i2-i5. doi: 10.1093/rap/rkad005. eCollection 2023 Apr. Rheumatol Adv Pract. 2023. PMID: 36968632 Free PMC article.
-
New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria®) Vaccine Administration.Vaccines (Basel). 2023 Feb 13;11(2):434. doi: 10.3390/vaccines11020434. Vaccines (Basel). 2023. PMID: 36851311 Free PMC article.
-
Do we miss rare adverse events induced by COVID-19 vaccination?Front Med (Lausanne). 2022 Oct 10;9:933914. doi: 10.3389/fmed.2022.933914. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36300183 Free PMC article. Review.
-
Prevalence of rheumatoid arthritis following COVID-19 vaccine: An autoimmune disorder.Ann Med Surg (Lond). 2022 Oct;82:104628. doi: 10.1016/j.amsu.2022.104628. Epub 2022 Sep 9. Ann Med Surg (Lond). 2022. PMID: 36101843 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical